Israeli army extends Hebron siege into second day
Israeli forces have maintained a tight closure on Hebron in the occupied West Bank for a second day, with Palestinian media reporting home raids, m...
China on Tuesday announced a ban on the import of genetic sequencers from U.S. medical equipment maker Illumina, just minutes after President Donald Trump's additional 10% tariff on Chinese goods took effect.
The ban, which will come into force on March 4, is part of a series of retaliatory measures implemented by Beijing in response to the new U.S. tariffs.
According to a statement by China’s commerce ministry, the ban follows the placement of Illumina on the “unreliable entity” list in February. The ministry cited that Illumina had suspended normal transactions with Chinese enterprises and taken discriminatory measures against them. Genetic sequencers are essential for determining DNA or RNA sequences, aiding scientists in studying genetic variations linked to diseases and diagnosing rare conditions. China accounts for about 7% of Illumina’s global sales.
Responding to inquiries, Illumina stated that it would continue to serve its customers in China and remain committed to operating in compliance with the latest guidelines from the Ministry of Commerce. The company is currently assessing the impact of the ban on its operations in the region.
The measure targets Illumina as part of a broader crackdown on U.S. firms, though Beijing has so far refrained from imposing restrictions on major U.S. household names. Analysts note that the move could bolster domestic competition, as shares in local rivals such as BGI Genomics and MGI Tech saw significant gains, with estimates suggesting a potential business opportunity of 750 million yuan ($103 million) for MGI Tech this year.
This development is one of several steps taken by China in its escalating trade dispute with the United States, following previous actions such as tariffs on $21 billion worth of American agricultural and food products and restrictions on other U.S. companies deemed unreliable.
Israeli military bulldozers have begun demolishing buildings in the West Bank city of Hebron on Friday, 23 October, following armed clashes with Palestinians that left two Israeli soldiers dead, according to the Israeli military.
Around 11,000 people joined a demonstration in Orléans on Saturday against the National Rally congress, according to the local prefecture.
Typhoon Champi swept past Taiwan on Saturday, leaving one person dead and more than 500 injured as strong winds and torrential rain brought down trees, cut power and disrupted transport across the island.
A powerful magnitude 7 earthquake has struck Tibet in southwestern China, killing 16 people and injuring 65, while forcing more than 12,000 residents to relocate as rescue teams respond to widespread aftershocks.
French President Emmanuel Macron on Friday described a deadly shooting in the towns of Trappes and La Verrière, west of Paris, as a racist attack and ‘a turning point’ for the country.
Around 11,000 people joined a demonstration in Orléans on Saturday against the National Rally congress, according to the local prefecture.
German police have detained a suspect after a major fire broke out at the historic Kehlsteinhaus, known as the “Eagle’s Nest”, a mountain retreat once used by senior Nazi officials, including Adolf Hitler.
Typhoon Champi swept past Taiwan on Saturday, leaving one person dead and more than 500 injured as strong winds and torrential rain brought down trees, cut power and disrupted transport across the island.
Canadian Prime Minister Mark Carney on Friday dismissed accusations that Canada planned to interfere in next month’s U.S. midterm elections, saying he was disappointed by comments from the American ambassador.
Kenya has recorded a second death from Ebola, the health ministry said late on Friday, as the outbreak that began in the Democratic Republic of Congo continues to spread across Africa.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment